Roger S. Chen

642 total citations
6 papers, 543 citations indexed

About

Roger S. Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Roger S. Chen has authored 6 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Roger S. Chen's work include Peptidase Inhibition and Analysis (2 papers), Multiple Myeloma Research and Treatments (2 papers) and NF-κB Signaling Pathways (2 papers). Roger S. Chen is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Multiple Myeloma Research and Treatments (2 papers) and NF-κB Signaling Pathways (2 papers). Roger S. Chen collaborates with scholars based in Switzerland and United States. Roger S. Chen's co-authors include David Stirling, George W. Muller, Faribourz Payvandi, Peter Schäfer, Linghua Zhang, Hon‐Wah Man, Lei Wu, J. Blake Bartlett, Christopher C.W. Hughes and Laura G. Corral and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Cellular Immunology.

In The Last Decade

Roger S. Chen

6 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger S. Chen Switzerland	6	315	304	182	76	69	6	543
Ruriko Tanaka Japan	14	346 1.1×	357 1.2×	159 0.9×	103 1.4×	199 2.9×	23	727
Tina M. Woo United States	7	380 1.2×	620 2.0×	269 1.5×	39 0.5×	61 0.9×	13	751
Marja Dubay United States	11	124 0.4×	477 1.6×	168 0.9×	36 0.5×	59 0.9×	14	567
Nobuyoshi Tsuruoka Japan	15	161 0.5×	354 1.2×	174 1.0×	69 0.9×	40 0.6×	31	562
P. Oriol France	8	324 1.0×	545 1.8×	231 1.3×	92 1.2×	87 1.3×	21	781
Deborah Chirnomas United States	10	237 0.8×	580 1.9×	294 1.6×	48 0.6×	148 2.1×	18	898
Masanori Umeda Japan	15	113 0.4×	275 0.9×	145 0.8×	53 0.7×	68 1.0×	59	533
Hai Lin China	19	621 2.0×	838 2.8×	207 1.1×	86 1.1×	158 2.3×	41	1.1k
Denise Niewerth Netherlands	12	322 1.0×	530 1.7×	240 1.3×	59 0.8×	41 0.6×	20	697
Ramesh Jayaraman Singapore	15	253 0.8×	433 1.4×	352 1.9×	72 0.9×	344 5.0×	18	898

Countries citing papers authored by Roger S. Chen

Since Specialization

Citations

This map shows the geographic impact of Roger S. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger S. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger S. Chen more than expected).

Fields of papers citing papers by Roger S. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger S. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger S. Chen. The network helps show where Roger S. Chen may publish in the future.

Co-authorship network of co-authors of Roger S. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Roger S. Chen. A scholar is included among the top collaborators of Roger S. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger S. Chen. Roger S. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lu, Ling, Faribourz Payvandi, Lei Wu, et al.. (2008). The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvascular Research. 77(2). 78–86. 183 indexed citations

2.

Zhang, Linghua, Lei Wu, Heather K. Raymon, et al.. (2006). The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumor Necrosis Factor-α Production with Antitumor Activity. Cancer Research. 66(2). 951–959. 77 indexed citations

3.

Payvandi, Faribourz, Lei Wu, Anastasia Parton, et al.. (2005). Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB, OCT-1, or NF-AT. Journal of Interferon & Cytokine Research. 25(10). 604–616. 40 indexed citations

4.

Payvandi, Faribourz, Lei Wu, Peter Schäfer, et al.. (2004). Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-α, IL-1β, and LPS-stimulated human PBMC in a partially IL-10-dependent manner. Cellular Immunology. 230(2). 81–88. 65 indexed citations

5.

Teo, Steve K., Yong Chen, George W. Muller, et al.. (2003). Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline. Chirality. 15(4). 348–351. 23 indexed citations

6.

Schäfer, Peter, Anita K. Gandhi, Roger S. Chen, et al.. (2003). Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1222–1232. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact